Yali Wang Selected Research

Gurigumu-7

6/2016

Hepato-protective effects and chemical constituents of a bioactive fraction of the traditional compound medicine-Gurigumu-7.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yali Wang Research Topics

Disease

51	Neoplasms (Cancer) 06/2022 - 01/2012
13	Inflammation (Inflammations) 01/2022 - 01/2005
11	Stroke (Strokes) 01/2021 - 06/2014
9	COVID-19 03/2022 - 01/2020
9	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 08/2013
8	Infections 11/2021 - 08/2014
7	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
7	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 10/2014
6	Hypoxia (Hypoxemia) 01/2022 - 05/2010
6	Carcinogenesis 01/2021 - 04/2017
5	Necrosis 09/2022 - 11/2015
5	Neoplasm Metastasis (Metastasis) 01/2018 - 11/2014
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2014
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 10/2016
4	Atrial Fibrillation 11/2021 - 01/2021
4	Hypertension (High Blood Pressure) 01/2021 - 01/2020
4	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2019
4	Brain Ischemia (Cerebral Ischemia) 01/2020 - 06/2014
3	Fibrosis (Cirrhosis) 01/2022 - 03/2019
3	Body Weight (Weight, Body) 04/2021 - 01/2016
3	Rheumatoid Arthritis 01/2021 - 10/2015
3	Vascular Remodeling 01/2021 - 02/2010
3	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2017
3	Arthritis (Polyarthritis) 01/2021 - 02/2014
3	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2015
3	Esophageal Squamous Cell Carcinoma 01/2021 - 01/2019
3	Bacterial Infections (Bacterial Infection) 01/2020 - 12/2019
3	Hematologic Neoplasms (Hematological Malignancy) 08/2018 - 11/2013
3	Carcinoma (Carcinomatosis) 08/2018 - 01/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016 - 02/2008
3	Uveitis 10/2009 - 06/2004
3	Anterior Uveitis 06/2006 - 06/2004
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2022 - 01/2017
2	Pregnancy Complications 01/2022 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2021 - 01/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2021 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 06/2021 - 01/2021
2	Ischemic Stroke 01/2021 - 01/2017
2	Wounds and Injuries (Trauma) 01/2021 - 11/2012

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 02/2022 - 06/2006
14	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2019
14	Pharmaceutical PreparationsIBA 01/2022 - 05/2015
9	Biological ProductsIBA 06/2022 - 05/2015
7	CytokinesIBA 03/2022 - 03/2016
6	EnzymesIBA 05/2022 - 11/2013
6	Long Noncoding RNAIBA 01/2021 - 01/2016
5	LipidsIBA 09/2022 - 11/2012
5	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 02/2015
5	Capsules (Microcapsules)IBA 01/2017 - 10/2015
4	C-Reactive ProteinIBA 02/2022 - 01/2017
4	Neuroprotective AgentsIBA 10/2021 - 11/2015
4	Messenger RNA (mRNA)IBA 01/2021 - 09/2008
4	Phosphotransferases (Kinase)IBA 01/2021 - 01/2016
4	MicroRNAs (MicroRNA)IBA 01/2021 - 12/2019
4	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
4	xinfengIBA 01/2017 - 10/2015
3	AntibodiesIBA 03/2022 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 03/2022 - 01/2016
3	MatrinesIBA 01/2022 - 12/2014
3	CurcuminIBA 01/2022 - 08/2014
3	Therapeutic UsesIBA 01/2022 - 08/2018
3	Circular RNAIBA 12/2021 - 01/2021
3	AntioxidantsIBA 01/2021 - 01/2015
3	Antihypertensive Agents (Antihypertensives)IBA 02/2020 - 03/2019
3	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2017
3	Protein Kinases (Protein Kinase)IBA 01/2020 - 09/2019
3	PolymersIBA 01/2020 - 01/2016
3	AntigensIBA 07/2017 - 09/2007
3	Small Interfering RNA (siRNA)IBA 05/2017 - 01/2016
3	Interleukin-17 (Interleukin 17)IBA 01/2017 - 10/2009
3	LigandsIBA 01/2016 - 02/2014
3	Clioquinol (Vioform)FDA Link 11/2015 - 11/2013
3	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 11/2010 - 02/2010
3	Complement System Proteins (Complement)IBA 06/2006 - 01/2005
2	Amino Acids FDA Link 09/2022 - 07/2020
2	Hormones (Hormone)IBA 07/2022 - 09/2008
2	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2022 - 09/2008
2	Serum AlbuminIBA 02/2022 - 01/2021
2	fibrin fragment D (D-dimer)IBA 02/2022 - 01/2020
2	Estrogen ReceptorsIBA 01/2022 - 12/2021
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022 - 12/2019
2	Phosphodiesterase 4 InhibitorsIBA 01/2022 - 12/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 08/2018
2	CarbohydratesIBA 11/2021 - 06/2004
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2021 - 12/2019
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2021 - 01/2021
2	NucleosidesIBA 07/2021 - 10/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2021 - 01/2021
2	Peptides (Polypeptides)IBA 01/2021 - 07/2017
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2020
2	CaspasesIBA 01/2021 - 01/2020

Therapy/Procedure

25	Therapeutics 03/2022 - 01/2013
7	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
6	Immunotherapy 01/2022 - 07/2017
4	Transplantation 01/2022 - 01/2013
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 07/2016
3	Radiotherapy 01/2020 - 11/2014
2	Aftercare (After-Treatment) 09/2022 - 12/2016
2	Precision Medicine 01/2022 - 01/2019